-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Intuitive Surgical, Lowers Price Target to $651

Benzinga·04/23/2026 15:19:28
Listen to the news
Barclays analyst Matt Miksic maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and lowers the price target from $712 to $651.